171 related articles for article (PubMed ID: 18673191)
1. HCV and autoimmunity.
Ferri S; Muratori L; Lenzi M; Granito A; Bianchi FB; Vergani D
Curr Pharm Des; 2008; 14(17):1678-85. PubMed ID: 18673191
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune manifestations in viral hepatitis.
Vergani D; Mieli-Vergani G
Semin Immunopathol; 2013 Jan; 35(1):73-85. PubMed ID: 23010889
[TBL] [Abstract][Full Text] [Related]
3. Organ-specific autoimmunity and genetic predisposition in interferon-treated HCV-related chronic hepatitis patients.
Floreani A; Chiaramonte M; Greggio NA; Fabris P; De Lazzari F; Naccarato R; Betterle C
Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):71-6. PubMed ID: 9615270
[TBL] [Abstract][Full Text] [Related]
4. Differences in immune recognition of cytochrome P4502D6 by liver kidney microsomal (LKM) antibody in autoimmune hepatitis and chronic hepatitis C virus infection.
Ma Y; Peakman M; Lobo-Yeo A; Wen L; Lenzi M; Gäken J; Farzaneh F; Mieli-Vergani G; Bianchi FB; Vergani D
Clin Exp Immunol; 1994 Jul; 97(1):94-9. PubMed ID: 8033426
[TBL] [Abstract][Full Text] [Related]
5. No evidence of autoimmunity in 6-year-old children immunized at birth with recombinant hepatitis B vaccine.
Belloni C; Avanzini MA; De Silvestri A; Martinetti M; Pasi A; Coslovich E; Autelli M; Masanti ML; Cuccia M; Tinelli C; Rondini G; Lorini R
Pediatrics; 2002 Jul; 110(1 Pt 1):e4. PubMed ID: 12093985
[TBL] [Abstract][Full Text] [Related]
6. B cells and HCV: an infection model of autoimmunity.
Sansonno L; Tucci FA; Sansonno S; Lauletta G; Troiani L; Sansonno D
Autoimmun Rev; 2009 Dec; 9(2):93-4. PubMed ID: 19318140
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of hepatitis C serum antibody in autoimmune diseases.
Agmon-Levin N; Ram M; Barzilai O; Porat-Katz BS; Parikman R; Selmi C; Gershwin ME; Anaya JM; Youinou P; Bizzaro N; Tincani A; Tzioufas AG; Cervera R; Stojanovich L; Martin J; Gonzalez-Gay MA; Valentini G; Blank M; SanMarco M; Rozman B; Bombardieri S; De Vita S; Shoenfeld Y
J Autoimmun; 2009; 32(3-4):261-6. PubMed ID: 19356903
[TBL] [Abstract][Full Text] [Related]
8. [Immunopathology of chronic liver diseases].
Meyer zum Büschenfelde KH
Verh Dtsch Ges Pathol; 1995; 79():186-97. PubMed ID: 8600684
[TBL] [Abstract][Full Text] [Related]
9. MHC haplotype and B cell autoimmunity: Correlation with pathogenic IgG autoantibody subclasses and Fc glycosylation patterns.
Nogueira Almeida L; Clauder AK; Meng L; Ehlers M; Arce S; Manz RA
Eur J Immunol; 2022 Feb; 52(2):197-203. PubMed ID: 34609741
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of liver/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease.
Muratori L; Lenzi M; Ma Y; Cataleta M; Mieli-Vergani G; Vergani D; Bianchi FB
Gut; 1995 Sep; 37(3):406-12. PubMed ID: 7590439
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C-associated autoimmunity in patients coinfected with HIV.
Woitas RP; Stoschus B; Terjung B; Vogel M; Kupfer B; Brackmann HH; Rockstroh JK; Sauerbruch T; Spengler U
Liver Int; 2005 Dec; 25(6):1114-21. PubMed ID: 16343060
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of thyroid autoantibodies in hepatitis C and hepatitis B infection in China.
Yang R; Shan Z; Li Y; Fan C; Li C; Teng W
Intern Med; 2011; 50(8):811-5. PubMed ID: 21498927
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
14. Islet cell and thyroid antibody prevalence in patients with hepatitis C virus infection: effect of treatment with interferon.
Piquer S; Hernández C; Enriquez J; Ross A; Esteban JI; Genescà J; Bonifacio E; Puig-Domingo M; Simó R
J Lab Clin Med; 2001 Jan; 137(1):38-42. PubMed ID: 11150022
[TBL] [Abstract][Full Text] [Related]
15. Multispecific T cell response and negative HCV RNA tests during acute HCV infection are early prognostic factors of spontaneous clearance.
Spada E; Mele A; Berton A; Ruggeri L; Ferrigno L; Garbuglia AR; Perrone MP; Girelli G; Del Porto P; Piccolella E; Mondelli MU; Amoroso P; Cortese R; Nicosia A; Vitelli A; Folgori A
Gut; 2004 Nov; 53(11):1673-81. PubMed ID: 15479691
[TBL] [Abstract][Full Text] [Related]
16. Molecular mimicry of human cytochrome P450 by hepatitis C virus at the level of cytotoxic T cell recognition.
Kammer AR; van der Burg SH; Grabscheid B; Hunziker IP; Kwappenberg KM; Reichen J; Melief CJ; Cerny A
J Exp Med; 1999 Jul; 190(2):169-76. PubMed ID: 10432280
[TBL] [Abstract][Full Text] [Related]
17. High prevalence of a variety of autoantibodies in a population of hepatitis C virus-infected individuals.
Navarta LM; Espul CA; Acosta-Rivero N
APMIS; 2018 Jun; 126(6):515-522. PubMed ID: 29924449
[TBL] [Abstract][Full Text] [Related]
18. [Autoimmunity and HCV].
Bianchi FB
Recenti Prog Med; 1993 Nov; 84(11):774-8. PubMed ID: 8290791
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies in systemic autoimmune diseases: specificity and pathogenicity.
Suurmond J; Diamond B
J Clin Invest; 2015 Jun; 125(6):2194-202. PubMed ID: 25938780
[TBL] [Abstract][Full Text] [Related]
20. T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus--positive blood donors without viremia.
Lechmann M; Ihlenfeldt HG; Braunschweiger I; Giers G; Jung G; Matz B; Kaiser R; Sauerbruch T; Spengler U
Hepatology; 1996 Oct; 24(4):790-5. PubMed ID: 8855177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
